Published in Cancer Weekly, January 26th, 2010
"Swiss nude mice bearing intraperitoneal tumor cell xenografts were injected with 37 MBq (370 MBq/mg) of internalizing (anti-HER1) I-125-m225 or noninternalizing (anti-CEA) I-125-35A7 mAbs at days 4 and 7 after tumor cell grafting. Nonspecific toxicity was assessed using...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.